Presentation is loading. Please wait.

Presentation is loading. Please wait.

Drug-Coated Balloon Angioplasty Confers No Advantage in the Treatment of Femoropopliteal Disease When Stenting Is Required  Brian Tiu, MD, Michael Shih,

Published byLucy Davidson Modified over 5 years ago

Similar presentations

Presentation on theme: "Drug-Coated Balloon Angioplasty Confers No Advantage in the Treatment of Femoropopliteal Disease When Stenting Is Required  Brian Tiu, MD, Michael Shih,"— Presentation transcript:

1 Drug-Coated Balloon Angioplasty Confers No Advantage in the Treatment of Femoropopliteal Disease When Stenting Is Required  Brian Tiu, MD, Michael Shih, MD, Alexander Shiferson, DO, Qing Hua Pu, MD, Theresa Jacob, Robert Rhee, MD  Journal of Vascular Surgery  Volume 68, Issue 2, Pages e22-e23 (August 2018) DOI: /j.jvs Copyright © Terms and Conditions

2 Fig Left - Primary patency of all stented patients utilizing drug coated balloon angioplasty versus plain balloon angioplasty. Right - Primary patency of all patients utilizing drug coated balloon angioplasty versus all patients utilizing plain balloon angioplasty Journal of Vascular Surgery  , e22-e23DOI: ( /j.jvs ) Copyright © Terms and Conditions

Download ppt "Drug-Coated Balloon Angioplasty Confers No Advantage in the Treatment of Femoropopliteal Disease When Stenting Is Required  Brian Tiu, MD, Michael Shih,"

Similar presentations

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.
John Blebea, MD, Kenneth Ouriel, MD, Richard M. Green, MD, William M

John Blebea, MD, Kenneth Ouriel, MD, Richard M. Green, MD, William M
Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.
Carotid stenting versus endarterectomy in patients undergoing reintervention after prior carotid endarterectomy  Margriet Fokkema, MD, Gert Jan de Borst,

Carotid stenting versus endarterectomy in patients undergoing reintervention after prior carotid endarterectomy  Margriet Fokkema, MD, Gert Jan de Borst,
Comparison of surgical bypass with angioplasty and stenting of superficial femoral artery disease  Mahmoud B. Malas, MD, MHS, Ngozi Enwerem, MBBS, Umair.

Comparison of surgical bypass with angioplasty and stenting of superficial femoral artery disease  Mahmoud B. Malas, MD, MHS, Ngozi Enwerem, MBBS, Umair.
Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.
Balloon angioplasty versus Viabahn stent graft for treatment of failing or thrombosed prosthetic hemodialysis grafts  Thomas Vesely, MD, William DaVanzo,

Balloon angioplasty versus Viabahn stent graft for treatment of failing or thrombosed prosthetic hemodialysis grafts  Thomas Vesely, MD, William DaVanzo,
Primary stenting of femoropopliteal atherosclerotic lesions using new helical interwoven nitinol stents  Yiu Che Chan, MBBS, BSc, MD, FRCS, Stephen W.

Primary stenting of femoropopliteal atherosclerotic lesions using new helical interwoven nitinol stents  Yiu Che Chan, MBBS, BSc, MD, FRCS, Stephen W.
Brian G. Peterson, MD, Jon S. Matsumura, MD 

Brian G. Peterson, MD, Jon S. Matsumura, MD 
Steven T. W. van Haelst, MD, Stefanie M. O. Peeters Weem, MD, Frans L

Steven T. W. van Haelst, MD, Stefanie M. O. Peeters Weem, MD, Frans L
Stenting of femoropopliteal lesions using interwoven nitinol stents

Stenting of femoropopliteal lesions using interwoven nitinol stents
A percutaneous arterial closure protocol can decrease complications after endovascular interventions in vascular surgery patients  Philip P. Goodney,

A percutaneous arterial closure protocol can decrease complications after endovascular interventions in vascular surgery patients  Philip P. Goodney,
Ali F. AbuRahma, MD, J. David Hayes, MD, Sarah K

Ali F. AbuRahma, MD, J. David Hayes, MD, Sarah K
Balloon angioplasty compared with stenting for treatment of femoropopliteal occlusive disease: A meta-analysis  Bibombe Patrice Mwipatayi, MMed (Surg),

Balloon angioplasty compared with stenting for treatment of femoropopliteal occlusive disease: A meta-analysis  Bibombe Patrice Mwipatayi, MMed (Surg),
Revision using distal inflow is a safe and effective treatment for ischemic steal syndrome and pathologic high flow after access creation  Thomas M. Loh,

Revision using distal inflow is a safe and effective treatment for ischemic steal syndrome and pathologic high flow after access creation  Thomas M. Loh,
Ali F. AbuRahma, MD  Journal of Vascular Surgery 

Ali F. AbuRahma, MD  Journal of Vascular Surgery 
Louis L. Nguyen, MD, MBA, MPH  Journal of Vascular Surgery 

Louis L. Nguyen, MD, MBA, MPH  Journal of Vascular Surgery 
Balloon angioplasty versus Viabahn stent graft for treatment of failing or thrombosed prosthetic hemodialysis grafts  Thomas Vesely, MD, William DaVanzo,

Balloon angioplasty versus Viabahn stent graft for treatment of failing or thrombosed prosthetic hemodialysis grafts  Thomas Vesely, MD, William DaVanzo,
Long-term safety of cilostazol in patients with peripheral artery disease: The CASTLE study (Cilostazol: A Study in Long-term Effects)  William R. Hiatt,

Long-term safety of cilostazol in patients with peripheral artery disease: The CASTLE study (Cilostazol: A Study in Long-term Effects)  William R. Hiatt,
Michael C. Stoner, MD, Dorian J. deFreitas, MD, Sachin V

Michael C. Stoner, MD, Dorian J. deFreitas, MD, Sachin V

Similar presentations

Ads by Google